Bristol-Myers Squibb is the 2017 ISPE Facility of the Year Category Winner for Facility Integration for their Biologics Development Building (BDB) and Clinical Manufacturing Building (CMB) located in Devens, Massachusetts, USA. Projects selected in the Facility Integration category exemplify the application of good design practices and superior conceptual planning leading to excellent integration of facility and process which yields efficient, clean, pleasant environments promoting business advantages for staff and enterprise while encouraging excellent processing outcomes.
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines to help patients prevail over serious diseases. The success of this winning project relied on people who were bold, focused, innovative, and passionate about working on a team, which brought unique and individual talents to bear. Their key focus in the planning, construction, and operation of these two new facilities was to create the broadest possible integration—into the existing campus, each other, the environment. It also was focused to meet the creative and intellectual needs of their workforce to maximize collaboration and flexibility, both in the new buildings and on the campus.
While Bristol-Myers Squibb overcame several challenges to make this possible, perhaps the most remarkable was the very nature of the project itself: two separate facilities, designed by two separate architects and constructed at the same time by the same construction manager on an already fully operational campus. It goes without saying that it takes a high a level of collaboration, coordination, and innovative delivery methods to execute a project like this one, and the same commitment to collaboration during construction is woven into the fundamental fabric of the projects’ design principles and their ongoing operating philosophies.
ISPE congratulations Bristol-Myers Squibb’s team for their achievements and their FOYA award-winning entry for Facility Integration. Learn more about the 2017 FOYA Facility Integration Category winner, BMS-Deven and their Biologics Development Building (BDB) and Clinical Manufacturing Building project.
Facility of the Year Awards Banquet
Join ISPE and prominent industry leaders as we recognize the 2017 Facility of the Year Awards (FOYA) Category Winners for their innovation and creativity in pharmaceutical and biotechnology facility design, construction, and operation at the FOYA Banquet on the evening of Tuesday, 6 June 2017 in Arlington, VA, USA during the ISPE/FDA/PQRI Quality Manufacturing Conference.
Stability sampling and testing are key to ensuring that products maintain safety, identity, strength, purity, and quality throughout their claimed shelf life. It is also a regulatory requirement per ICH Q5. However, storing product samples in different environmental conditions, testing those samples for three to five years (or more) after initial manufacture, and properly analyzing and...
ISPE hosted more than 450 attendees in person and virtually for the 2024 ISPE Aseptic Conference in Vienna, Austria. Keynotes and education sessions provided a comprehensive overview of key topics and trends...
Biopharmaceutical facility design is a critical aspect of the industry. Overall cost pressures in the global health system, regional requirements to deploy manufacturing rather than centralize manufacturing in one location, technology enhancements in cell biology and format, flexibility to accommodate multi-product campaigns with different production schedules, and speed-to-market are among...